Bromelain for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Bromelain for Health & Longevity

Created on 09/07/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Pineapple-stem enzymes with real evidence in two narrow places: swelling and pain after wisdom-tooth surgery, and a hospital gel that clears dead tissue from deep burns. Older controlled trials point to faster sinus relief. Joint, recovery, blood-vessel and blood-sugar claims are thin. Well tolerated apart from allergy. Most retail capsules fail independent enzyme testing. (Full Review)

Protocol

Standard systemic dose
500-1,000 mg daily
Stem bromelain in two or three divided doses, at least 45 min before or 2 h after food. Colitis benefit at 400 mg daily.
Standard digestive dose
200-2,000 mg per meal
With each protein-containing meal; acts on food protein, not via absorption.
Potency, not weight, is the real dose
About 1,200 gelatin digesting units per 500 mg
From a 2,400-unit-per-gram powder; milligrams alone say nothing about actual protease activity.
Time to effect
Swelling & sinus symptoms
2-7 days
Perioperative courses run 3-14 days; sinus courses 5-10 days.
Colitis activity
8 weeks
Endpoint of a single trial; replication is needed.
Joint outcomes
4-16 weeks
Improvement continues across the course; the data rest on combination products.

Benefits

Contraindications
  • Documented immunoglobulin E sensitisation to pineapple, papain, latex, bee venom or olive pollen
  • Bleeding disorder, platelet count below 100,000 per microlitre, or unstable international normalised ratio above 3
  • Within 14 days of planned major surgery, or within 14 days after it while still on therapeutic anticoagulation
  • Active peptic ulcer or gastrointestinal bleeding
  • Pregnant and breastfeeding women
    •
Key Interactions
  • Anticoagulants (warfarin, apixaban, rivaroxaban, dabigatran): Caution
  • Antiplatelet drugs (aspirin, clopidogrel, ticagrelor, prasugrel): Caution
  • Over-the-counter non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, low-dose aspirin): Caution
  • Tetracyclines and penicillins (tetracycline, amoxicillin): Monitor
  • Sedatives and central nervous system depressants (benzodiazepines, opioids): No established interaction
  • Supplement interactions with additive antiplatelet effects: Caution (fish oil, garlic, ginkgo, high-dose vitamin E, nattokinase)
  • Supplements with additive anti-inflammatory effects: Generally desirable (curcumin, quercetin, boswellia)
  • Other interventions: Caution around elective surgery, dental extraction and cosmetic procedures

Risk & Side Effects

  • High: Mild gastrointestinal and systemic adverse events; procedural harms from topical enzymatic debridement
  • Medium: Allergic and hypersensitivity reactions
    •
  • Low: Bleeding, bruising and heavier menstrual flow; dose-related rise in heart rate
  • Speculative: Immune activation in autoimmune disease; mucosal injury and weight loss at high doses

Monitoring

Marker Target Why
High-sensitivity C-reactive protein Below 1.0 mg/L Primary inflammatory target
Fibrinogen 200-300 mg/dL Clot-forming protein bromelain is claimed to lower
Platelet count 175-250 x 10⁹/L Bleeding safety margin
International normalised ratio 2.0-3.0 if anticoagulated; otherwise 0.9-1.1 Detects any additive anticoagulant effect
Alanine aminotransferase 10-26 U/L in men, 10-19 U/L in women Liver safety on extended courses
Estimated glomerular filtration rate Above 90 mL/min/1.73 m² Kidney safety on extended courses
Specific immunoglobulin E to pineapple and latex Below 0.35 kU/L (negative) Identifies the one potentially serious risk before exposure
Symptom score for the treated condition No fixed target; change from the individual's own baseline Defines whether the course worked

Cadence: Baseline panel before starting; clotting studies at 1-2 weeks on anticoagulants; inflammatory markers and liver enzymes at 8-12 weeks for extended courses; then every 6-12 months if use becomes habitual.

Qualitative Assessment

  • Swelling and bruising at the site, photographed at fixed distance
  • Joint pain, morning stiffness duration, and stair, standing and walking capacity
  • Nasal congestion, postnasal drip and days to resolution in a sinus episode
  • Bowel frequency, urgency and blood in stool during colitis treatment
  • Digestive comfort after protein-heavy meals: fullness, bloating and belching
  • New bruising, gum bleeding or nosebleeds: earliest anticoagulant signal
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.